Prémiový dluhový cenný papír VACCINATION AUTOCALL |
|
ISIN: XS2364764303 |
2024/03/28 00:00:00 | |
---|---|
Bid | Ask |
93.84 | - |
Minimum yield | - |
Difference | 0.05%(0.05) |
General attributes | |
---|---|
Type of bond | Structured bonds and notes |
Bond style | senior |
Issuer type | financial institution |
Country of issue | DE |
Current coupon | - |
Coupon style | variable |
Coupon payment date | 2024/10/11 |
Coupon payment period | at maturity |
Yield to maturity p.a. (before capital gains tax) | - |
Value date | 2021/10/11 |
Maturity | 2024/10/11 |
Repayment value | 0 |
Currency | CZK |
Nominal value | 10,000 |
Capital gains tax | - |
Accrued Interest | - |
|
Performance since inception. Performances under 12 month have only little informative value because of the short maturity. Information about previous performance does not guarantee future performance. Source: Česká spořitelna, a. s. |
Advantages | Details you should be aware of |
What does the Prémiový dluhový cenný papír VACCINATION AUTOCALL offer?
|
Please note that the target market of this investment instrument is listed below. If you do not meet any of the listed parameters, you may be outside the specified target market!
The target market defines the set of investors (retail clients) for whom the investment product is intended.
This investment product is intended for investors who:
* have sufficient knowledge and/or experience regarding structured products and shares.
* seek investment profit
* are able to accept a level of risk that is in accordance with the risk indicator of the product specified in General attributes.
* In the event of an unfavorable development of the investment, they are able to bear the possible loss, which is ilustrated by performance scenarios, see Key Information Document (KID).
* are interested in holding the product until the maturity specified in General attributes.
This investment product is not intended for investors (negative product target market), who:
* do not have sufficient knowledge regarding structured investment instruments and shares * are unable to bear the loss of invested funds indicated in the Key Information Document (KID) in the event of an unfavorable development of the investment The client's compatibility with the product's target market will be evaluated during the purchase process.
----------------------------------------------------------
|
Description | |
---|---|
PDCP VACCINATION AUTOCALL with the option of automatic early repayment provides the opportunity to gain an attractive annual yield of 8% (see Note). The total yield for its three-year duration can then reach up to 24%. The payout of a yield and nominal value of PDCP VACCINATION AUTOCALL is derived from the price trend of the shares of three leading pharmaceutical companies, Pfizer, Moderna and Johnson & Johnson. General awareness of these companies has been raised in recent months as they were among the first in the world to place an effective COVID-19 vaccine on the market. This year it is expected that thanks to the successful vaccines, the revenues above all of Pfizer and Moderna will reach record levels. Analysts expect a gradual decrease in the revenues of these companies up to 2023 with increasing vaccine coverage rates and a decline in the pandemic.Issuer: Goldman, Sachs & Co. Wertpapier GmbH Guarantor: The Goldman Sachs Group, Inc. (S&P's BBB+ / Moody's A3 / Fitch A) Underlying shares: Pfizer Inc., Moderna Inc. and Johnson & Johnson Subscription period: 21 September 2021 (9.00) – 4 October 2021 (16.00) You will find more information in the leaflet |
|
Payment notes | |
---|---|
How does Prémiový dluhový cenný papír VACCINATION AUTOCALL work?
For more information see the leaflet |
|
Settlement | |
---|---|
|
|
Secondary market | |
---|---|
---------------------------------------- Note 3: The risk weight is on a scale from 1 to 7 from the potentially lower risk and yield 1 to the potentially higher risk and yield 7 provided that you keep the asset until the maturity date. The actual risk may differ considerably if you sell early. The risk-weighted asset is a guide for the comparison of the risk rate of this product with others. It shows how likely it is for you to lose money as a consequence of a fluctuation on the markets, or because the issuer will not be able to pay out the money. |
|
Disclaimer |
---|
In the period before maturity, the bond price can fluctuate above and below the bond face value depending on the development of the interest rate and underlying asset. A bond can ben sold even before the maturity date, for the price pursuant to the pricelist of the issuer. Our consultants will give you detail information on the advantages and risks of investment in bonds. The information sources used are generally regarded as reliable, although Česká spořitelna and Erste Group Bank AG cannot guarantee the correctness and completeness of the information contained therein. The aim of this web page is to give information on the services and products contained therein; it is not a binding proposal establishing any rights and obligations for participants. All information you can find here is of informative nature only. Before using the web page for investment, a specialized Česká spořitelna consultant should be consulted. |